Anaconda Biomed, a CataloniaBio & HealthTech member, appointed two new senior executives, Dr Lieven Huysse as Chief Medical Officer (CMO) and Jordi Cardona that will serve as its new Manufacturing Director.
As Anaconda Biomed’s CMO, Dr. Huysse will lead the implementation of clinical trials of the company’s breakthrough advanced thrombectomy system for the treatment of ischemic stroke. Dr. Huysse brings to the company more than 20 years of senior leadership experience in the medical device and pharmaceutical fields (Intrinsic Therapeutics Inc., Menarini...).
Vidal brings to Anaconda more than 30 years of experience in the medical device field, leading production, quality control, engineering and research and development programs for large organisations.
Comments